Hale Cosmeceuticals Complexion Perfection Sunscreen SPF 20+

Hale Cosmeceuticals Complexion Perfection Sunscreen SPF 20 by

Drug Labeling and Warnings

Hale Cosmeceuticals Complexion Perfection Sunscreen SPF 20 by is a Otc medication manufactured, distributed, or labeled by Hale Cosmeceuticals, Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

HALE COSMECEUTICALS COMPLEXION PERFECTION SUNSCREEN SPF 20- titanium dioxide cream 
Hale Cosmeceuticals, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Hale Cosmeceuticals Complexion Perfection Sunscreen SPF 20+

Drug Facts

Active Ingredients

Titanium Dioxide 5.0%

Purpose

Sunscreen

Uses

• helps prevent sunburn 
• if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun.

Warnings

• For external use only

Do not use

• on damaged or broken skin

Stop use and ask a doctor if

• rash occurs

When using this product

• keep out of eyes. Rinse with water to remove.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center

Directions

• apply liberally 15 minutes before sun exposure 
• use a water resistant sunscreen if swimming or sweating
• reapply at least every 2 hours
• immediately after towel drying 
• at least every 2 hours 
• children under 6 months: Ask a doctor

Skin Cancer/Skin Aging Alert: Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to help prevent sunburn, not skin cancer or early skin aging.

Other Information

• protect this product from excessive heat and direct sun 
• may stain some fabrics

Inactive Ingredients

• Water, Caprylic/Capric Triglyceride, Polyhydroxystearic Acid, Stearic Acid, Alumina, Squalane, Glyceryl Stearate, PEG-100 Stearate, Cetearyl Alcohol, Ceteareth-20, Borago Officinalis Seed Oil, Sodium Hyaluronate, Iron Oxide, Niacinamide, Glycerin, Tocopheryl Acetate, Kojic Dipalmitate, Phenoxyethanol, Caprylyl Glycol, Sorbic Acid, Olea Europaea (Olive) Fruit Oil, Hydrogenated Vegetable Oil, Tocopheryl, Hydroxypropyl Cyclodextrin, Palmitoyl Tripeptide-38, Urea, Xanthum Gum, Disodium EDTA.

Questions or comments?

Visit www.halecosmeceuticals.com or call toll-free (800) 951-7005.

Package Labeling:

HALE COSMECEUTICALS COMPLEXION PERFECTION SUNSCREEN SPF 20 
titanium dioxide cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 71987-007
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP)	TITANIUM DIOXIDE	50 mg  in 1 mL

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
POLYHYDROXYSTEARIC ACID (2300 MW) (UNII: YXH47AOU0F)
STEARIC ACID (UNII: 4ELV7Z65AP)
ALUMINUM OXIDE (UNII: LMI26O6933)
SQUALANE (UNII: GW89575KF9)
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)
PEG-100 STEARATE (UNII: YD01N1999R)
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)
POLYOXYL 20 CETOSTEARYL ETHER (UNII: YRC528SWUY)
BORAGO OFFICINALIS SEED (UNII: 2GXJ790US0)
HYALURONATE SODIUM (UNII: YSE9PPT4TH)
FERRIC OXIDE RED (UNII: 1K09F3G675)
NIACINAMIDE (UNII: 25X51I8RD4)
GLYCERIN (UNII: PDC6A3C0OX)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
KOJIC DIPALMITATE (UNII: 13N249RWTM)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
SORBIC ACID (UNII: X045WJ989B)
OLIVE OIL (UNII: 6UYK2W1W1E)
TOCOPHEROL (UNII: R0ZB2556P8)
PALMITOYL LYSYLDIOXYMETHIONYLLYSINE (UNII: T7A529FB8O)
UREA (UNII: 8W8T17847W)
XANTHAN GUM (UNII: TTV12P4NEE)
EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 71987-007-01	30 mL in 1 TUBE; Type 0: Not a Combination Product	12/01/2020	12/31/2024

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph not final	part352	12/01/2020	12/31/2024

Labeler - Hale Cosmeceuticals, Inc. (168405822)

Revised: 12/2022

Document Id: efcf7ca9-a38f-323a-e053-2995a90a83fc

34390-5

Set id: b5a7ab9b-a78a-8ffc-e053-2995a90a2b8b

Version: 4

Effective Time: 20221214